ProPhase Labs Provides Update on Convertible Debt Conversions, Capital Structure, and Underlying Asset Value
Stocks in this Quantisnow insightHealth Care
Historical context for PRPH
Across the 9 sessions after earlier PRPH headlines, the stock closed higher 3 times and lower 6 times, with a median move of 5.4% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | PRPH | SPY |
|---|---|---|---|
| Dec 19, 2025 | ProPhase Labs Signs Non-Binding LOI for Proposed Reverse Merger with Advanced Biological Laboratories | -14.7% | +0.6% |
| Nov 26, 2025 | Join ProPhase Labs' Exclusive Live Investor Webinar and Q&A Session on December 1 | +0.7% | +0.7% |
| Nov 19, 2025 | ProPhase Labs Reported Results for the Third Quarter Ended September 30, 2025, and Will Hold a Virtual Conference Call Today at 2pm ET. | -9.5% | +0.4% |
| Nov 18, 2025 | ProPhase Labs, Inc. to Present Third Quarter 2025 Financial Results on November 19 | -2.6% | -0.8% |
| Nov 17, 2025 | ProPhase Labs Urges Shareholders to Vote by November 23 on Proxy Proposals | -5.4% | -0.9% |
| Oct 29, 2025 | ProPhase Labs Announces Publication of BE-Smart Esophageal Cancer Study in the Official Journal of the American College of Gastroenterology | -2.1% | +0.0% |
Quantisnow market dataNASDAQ
PRPH
ProPhase Labs Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Get push alerts for PRPH
Full PRPH profile on Quantisnow Follow PRPH and get a push notification the moment its next story breaks.